Synopsys investors faced a devastating single trading session as the company’s stock collapsed by nearly 36 percent. The dramatic sell-off on September 10th was triggered by third-quarter financial results for fiscal 2025 that fell significantly short of market expectations. The disappointing performance has not only shaken shareholder confidence but has also prompted legal investigations into the electronic design automation leader.
Financial Results Fall Short
The core of the crisis stems from Synopsys’ Q3 2025 financial metrics. The company reported revenue of $1.74 billion, a figure that substantially missed analyst projections. More concerning was the adjusted earnings per share of $3.39, which landed well below the anticipated $3.84.
Company leadership pointed to several contributing factors for the shortfall. The high-margin intellectual property (IP) business underperformed across the board. Furthermore, operational challenges are being compounded by export restrictions affecting the Chinese market and difficulties with a major foundry partner. Management issued a cautious outlook for the upcoming fourth quarter, reflecting these persistent headwinds.
Market Analysts Downgrade Outlook
The earnings disappointment triggered an immediate and widespread reaction from financial analysts. Baird downgraded its rating from “Outperform” to “Neutral,” simultaneously slashing its price target from $670 to $535.
Should investors sell immediately? Or is it worth buying Synopsys?
This sentiment was echoed across the research community:
- KeyBanc reduced its price target to $590
- Piper Sandler lowered its target to $630
- Needham cut its target to $550
- Rosenblatt shifted its rating from “Buy” to “Neutral,” setting a $605 price target
The primary concern cited by these firms was the ongoing weakness and uncertainty within Synopsys’ IP segment.
Legal Scrutiny Emerges
The severity of the share price decline, which amounted to a 35.84% drop, has attracted legal attention. The law firm Bragar Eagel & Squire has announced it is investigating Synopsys on behalf of investors who suffered losses. The probe will examine potential violations of securities laws or other possible unlawful business practices.
Despite strategic collaborations in the AI chip sector, such as its partnership with TSMC, Synopsys shares continue to struggle with the downward momentum. The immediate operational challenges now overshadow longer-term strategic initiatives, leaving a significant question mark over when, or if, investor confidence can be restored.
Ad
Synopsys Stock: Buy or Sell?! New Synopsys Analysis from March 25 delivers the answer:
The latest Synopsys figures speak for themselves: Urgent action needed for Synopsys investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.
Synopsys: Buy or sell? Read more here...
